Speaker

Mu-Sen Liu

Head Biochemist & Senior Scientist, Tango Therapeutics

Mu-Sen Liu, Head Biochemist & Senior Scientist at Tango Therapeutics, spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Mass Spectrometry-Based Kinetic & Site-Specific Profiling of Covalent Inhibitors Targeting VRK1”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Pharmacy & Pharmaceutical Sciences

Past appearances

4th Covalent Drug Discovery & Development Summit
20–22 Oct 2026Boston, United States of America
- SpeakerMass Spectrometry-Based Kinetic & Site-Specific Profiling of Covalent Inhibitors Targeting VRK1

More speakers at 4th Covalent Drug Discovery & Development Summit

David Anderson
Executive Director, Aclaris Therapeutics
Sara Buhrlage
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Antony Burton
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Jianwei (John) Che
Core Director, Dana-Farber Cancer Institute
Julian Dopstadt
Director, Eli Lilly
Jay Duffner
Director & Head of Discovery Biology, Frontier Medicines

See all 21 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mu-Sen Liu, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].